Home › Mycosis Fungoides › New York › New York City
Mycosis Fungoides clinical trials in New York City, NY
6 studies for Mycosis Fungoides are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Columbia University, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Photopheresis in Early-stage Mycosis Fungoides
RecruitingPhase 2
- Columbia University Irving Medical Center, New York
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Mycosis Fungoides trials in other cities
- Baldwin Park, CA8 studies
- Houston, TX7 studies
- Mountain View, CA6 studies
- Boston, MA4 studies
- Philadelphia, PA3 studies
- Tampa, FL3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- Scottsdale, AZ3 studies
- Rochester, MN3 studies
- East Norwalk, CT3 studies
- Queens, NY3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.